Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma - Concepedia

Concepedia

Publication | Closed Access

Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma

16

Citations

30

References

2024

Year

Aina Oliver‐Caldés, Marta Español‐Rego, Aintzane Zabaleta, Verónica González‐Calle, Sergio Navarro‐Velázquez, Susana Inogés, Ascensión López-Dı́az de Cerio, Valentín Cabañas, Nieves López‐Muñoz, Paula Rodríguez‐Otero,

Clinical Cancer Research

Abstract

Despite deep and sustained responses achieved with ARI0002h, we identified several biomarkers that correlate with poor outcomes.

References

	Year	Citations

Page 1